CHENIX Drug Patent Profile
Which patents cover Chenix, and what generic alternatives are available?
Chenix is a drug marketed by Leadiant Biosci Inc and is included in one NDA.
The generic ingredient in CHENIX is chenodiol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the chenodiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chenix
A generic version of CHENIX was approved as chenodiol by LGM PHARMA on October 22nd, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHENIX?
- What are the global sales for CHENIX?
- What is Average Wholesale Price for CHENIX?
Summary for CHENIX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4,535 |
| DailyMed Link: | CHENIX at DailyMed |
US Patents and Regulatory Information for CHENIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leadiant Biosci Inc | CHENIX | chenodiol | TABLET;ORAL | 018513-002 | Jul 28, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
